New imaging approaches to phaeochromocytomas and paragangliomas.
about
Head and neck paragangliomas: clinical and molecular genetic classificationPheochromocytoma: implications in tumorigenesis and the actual managementDiagnostic Imaging of Pregnant Women - The Role of Magnetic Resonance Imaging.The use of functional imaging in a patient with head and neck paragangliomas.Primary paraganglioma located between the thyroid gland and the left common carotid artery: A case reportPheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentMetastatic paraganglioma.Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphyAssociation of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.Diagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma.Pheochromocytoma and paraganglioma: current functional and future molecular imaging.Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.Pheochromocytoma and paraganglioma.EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRITransurethral resection of bladder tumour (TURBT) as an optional treatment method on pheochromocytoma of the urinary bladder.Management of von Hippel-Lindau disease-associated CNS lesions.MR in hypertension.Pheochromocytomas and paragangliomas: assessment of malignant potential.Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.Clinical and imaging overview of functional adrenal neoplasms.The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.Medical management of pheochromocytoma: Role of the endocrinologist.Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.
P2860
Q27016092-7966019D-AFC3-4017-8C3D-F4BDF60E48C7Q27024128-0784C163-AEEE-48D6-B30D-E86CB4CE41FBQ33606312-B530BE48-B03C-4418-84A8-38662080E9BCQ33736196-632DCB37-ADBA-4EE1-B461-EB8126728884Q34293351-C6D06772-32B9-4CEF-B7E4-858AE1369D9BQ34410500-742734CD-343B-4AB3-8CF6-ABC6A22FE4ECQ34480015-94E8F19C-18F6-40CB-88AE-590FE98750CEQ35198539-B38928E4-6390-4884-9BBE-85D1541BC3BEQ35562799-6D04BBDF-B084-487A-AD94-96F133095702Q35724965-34F5C15B-6B9E-44DD-B47B-424574240A48Q35972320-1E050B5D-BD00-40BC-AA41-28DF4C529613Q36021577-C8F1829F-1B3A-44C8-93D7-DEA06728727BQ36152379-88E7798B-0DF0-47FF-8947-B3D67DE7012FQ36467162-585A94F4-00CA-4355-ACCF-87E82E84256DQ36467722-A4453C22-B146-4173-B01F-6A75142E5837Q36535747-1F011FAA-72F4-4EBA-AB2C-0A7195571C07Q36833814-9EAB7CFF-8BE6-4493-9757-3D3EF4924033Q37939999-BEFC1849-ABE2-4D24-9330-A05D0F4E21ADQ37946292-CE4A408F-F17D-43E0-8791-F3B0E5191CE8Q37950920-F033F3A9-E715-41F7-A095-9CB06D73B6AAQ37962361-542EBF29-9EC2-4D3D-9EF6-E3F0C99E6168Q37987448-67FEE720-0373-4426-91CE-A1D5EC21B3B8Q37998534-97C121CE-B30B-4669-A9BC-337F1E0DD60CQ38348673-F935DBCA-176A-45B1-BE82-EE81894A371CQ38892571-FF1A3B54-4C46-49F7-B3BA-20A5870D6B5FQ39581733-77BC1B5C-AEFA-454E-BB73-55B829BEC355Q46715532-715F6CBF-33B0-4E27-B82C-70829809FBBCQ50055564-5A1EE55B-872C-4C8D-9739-1D8E11E89690Q51058465-60A660DF-54F6-4FA3-985B-CFA378C9E0B2
P2860
New imaging approaches to phaeochromocytomas and paragangliomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New imaging approaches to phaeochromocytomas and paragangliomas.
@ast
New imaging approaches to phaeochromocytomas and paragangliomas.
@en
New imaging approaches to phaeochromocytomas and paragangliomas.
@nl
type
label
New imaging approaches to phaeochromocytomas and paragangliomas.
@ast
New imaging approaches to phaeochromocytomas and paragangliomas.
@en
New imaging approaches to phaeochromocytomas and paragangliomas.
@nl
prefLabel
New imaging approaches to phaeochromocytomas and paragangliomas.
@ast
New imaging approaches to phaeochromocytomas and paragangliomas.
@en
New imaging approaches to phaeochromocytomas and paragangliomas.
@nl
P2093
P2860
P1476
New imaging approaches to phaeochromocytomas and paragangliomas.
@en
P2093
Bas Havekes
Edwin W Lai
Eleonora P M Corssmit
Johannes A Romijn
Kathryn King
P2860
P304
P356
10.1111/J.1365-2265.2009.03648.X
P50
P577
2009-06-08T00:00:00Z